News and Events

News from the UW Initiative to End Alzheimer's

  • Graphic image with Anchor Bay logo and stock graphic of shamrocks

    Shamrock Shuffle ‘23 raised over $16K for Alzheimer’s research

    On March 11, the Anchor Bay Bar and Grill in Wisconsin Rapids, WI, hosted its 2023 Shamrock Shuffle raising over $16,000 for the UW Initiative to End Alzheimer’s.

  • Photo of Nathaniel Chin and his father, Moe Chin.

    Dr. Nathaniel Chin Featured in UW SMPH ‘Quarterly’ Magazine

    Nathaniel Chin, MD, was featured in the latest issue of Quarterly magazine. In the article “How Grief Transformed Me,” Chin discusses how learning of his father’s Alzheimer’s disease diagnosis altered his professional trajectory.

  • Photo of David Adam on a road in Canada

    Pedaling to preserve memories down under with Dave and French Fry

    Dave Adam continues to be a champion for Alzheimer’s disease research. Dave is a Wisconsin man who cycled across Canada last year to help raise funds for Alzheimer’s disease programs at UW–Madison. This year he’s going down under to Australia and plans to bike 2,500 miles to support the UW Initiative to End Alzheimer’s.

  • Announcing the IEA Innovation Fund

    The UW Initiative to End Alzheimer’s (IEA) is pleased to announce the IEA Innovation Fund, providing project support for researchers from the Wisconsin Alzheimer’s Disease Research Center (ADRC) or Wisconsin Alzheimer’s Institute (WAI). The IEA Innovation Fund will help advance the University of Wisconsin–Madison’s Alzheimer’s disease researchers’ most promising ideas by providing an open door to funding opportunities that foster translational, innovative and inclusive advancements in Alzheimer’s disease research.

  • A closer look at lecanemab

    In January, the U.S. Food and Drug Administration (FDA) approved Leqembi (lecanemab-irmb) via the Accelerated Approval pathway to treat Alzheimer’s disease. Nathaniel Chin, MD, recently interviewed Cynthia Carlsson, MD, MS, and Sterling Johnson, PhD, to inform people about the research behind the new Alzheimer’s treatment, the drug's benefits and risks, and more.

  • Stock photo of a couple walking on a trail.

    UW study focuses on Alzheimer’s disease treatment and prevention in the Black community

    Carey Gleason, PhD, MS, and her research team’s African Americans Fighting Alzheimer's in Midlife (AA-FAIM) study is entering its second, five-year cycle and they are focused on making Alzheimer’s research more inclusive. 

  • Dr. Maria Mora Pinzon appointed to assistant professor

    Maria Mora Pinzon, MD, MS, FACPM, was recently appointed to assistant professor on the tenure track in the Division of Geriatrics and Gerontology at the University of Wisconsin School of Medicine and Public Health, where she will continue working with the Wisconsin Alzheimer’s Institute and expand her research program.

  • More News

Upcoming Events